CH624942A5 - Process for the preparation of 1-methyl-2-(alkylsulphonylphenoxymethyl)-5-nitroimidazoles - Google Patents
Process for the preparation of 1-methyl-2-(alkylsulphonylphenoxymethyl)-5-nitroimidazoles Download PDFInfo
- Publication number
- CH624942A5 CH624942A5 CH231377A CH231377A CH624942A5 CH 624942 A5 CH624942 A5 CH 624942A5 CH 231377 A CH231377 A CH 231377A CH 231377 A CH231377 A CH 231377A CH 624942 A5 CH624942 A5 CH 624942A5
- Authority
- CH
- Switzerland
- Prior art keywords
- methyl
- nitro
- imidazole
- phenoxymethyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
Description
624 942 624 942
2 2nd
PATENTANSPRUCH Verfahren zur Herstellung von l-Methyl-2-phenoxyme-thyl)-5-nitro-imidazolen der Formel I PATENT CLAIM Process for the preparation of l-methyl-2-phenoxy-methyl) -5-nitro-imidazoles of the formula I.
—ch2-o-/JV- r2 —Ch2-o- / JV- r2
CH2-0-/ ^ CH2-0- / ^
-R£ -R £
R- R-
(I) (I)
o2n o2n
Ii1 II1
M 3 CI)' M 3 CI) '
R^ R ^
worin R1 Methyl und R2 Methylsulfonyl oder Äthylsulfonyl und R3 Wasserstoff, Methyl oder Halogen bedeuten, dadurch gekennzeichnet, dass man l-Methyl-2-(phenoxymethyl)-5-ni-tro-imidazole der Formel II wherein R1 is methyl and R2 is methylsulfonyl or ethylsulfonyl and R3 is hydrogen, methyl or halogen, characterized in that l-methyl-2- (phenoxymethyl) -5-ni-tro-imidazole of the formula II
gefunden, found,
worin R1 Methyl, R2 Methylsulfonyl oder Äthylsulfonyl und io R3 Wasserstoff, Methyl oder Halogen wie Fluor, Chlor, Brom oder Jod bedeuten, das dadurch gekennzeichnet ist, dass man l-Methyl-2-(phenoxymethyl)-5-nitro-imidazole der Formel II wherein R1 is methyl, R2 is methylsulfonyl or ethylsulfonyl and io R3 is hydrogen, methyl or halogen such as fluorine, chlorine, bromine or iodine, which is characterized in that l-methyl-2- (phenoxymethyl) -5-nitro-imidazole of the formula II
A - R A - R
worin A ein Schwefelatom oder eine Sulfoxidgruppe (—SO-), R Methyl oder Äthyl, R1 Methyl und R3 Wasserstoff, Methyl oder Halogen bedeuten, oxidiert. wherein A is a sulfur atom or a sulfoxide group (—SO—), R is methyl or ethyl, R1 is methyl and R3 is hydrogen, methyl or halogen.
Gegenstand der CH-PS 616 926 sind l-Alkyl-2-(phen-oxymethyl)-5-nitro-imidazole der Formel CH-PS 616 926 relates to l-alkyl-2- (phen-oxymethyl) -5-nitro-imidazoles of the formula
R R
ch2-o ch2-o
R- R-
worin R1 Methyl oder Äthyl, R2 Trifluormethyl, Trichlorme-thyl, Nitro, Cyan, Methylsulfonyl oder Äthylsulfonyl und R3 Wasserstoff, Fluor, Chlor, Brom, Jod, Trifluormethyl, Tri-chlormethyl, Nitro oder Cyan bedeuten, Verfahren zur Herstellung dieser Verbindungen, sie enthaltende pharmazeutische Mittel und ihre Verwendung. wherein R1 is methyl or ethyl, R2 trifluoromethyl, trichloromethyl, nitro, cyano, methylsulfonyl or ethylsulfonyl and R3 is hydrogen, fluorine, chlorine, bromine, iodine, trifluoromethyl, tri-chloromethyl, nitro or cyano, process for the preparation of these compounds, them containing pharmaceutical compositions and their use.
Ferner sind l-Methyl-2-(phenoxymethyl)-5-nitro-imid-azole der Formel Furthermore, l-methyl-2- (phenoxymethyl) -5-nitro-imidazoles of the formula
OoN OoN
ch2-o worin R1 Nitro, Cyan, Methylsulfonyl oder Äthylsulfonyl und R2 Methyl oder Halogen bedeuten, Verfahren zur Herstellung dieser Verbindungen, sie enthaltende pharmazeutische Mittel und ihre Verwendung bereits vorgeschlagen worden. ch2-o wherein R1 is nitro, cyano, methylsulfonyl or ethylsulfonyl and R2 is methyl or halogen, processes for the preparation of these compounds, pharmaceutical compositions containing them and their use have already been proposed.
Es wurde nun ein Verfahren zur Herstellung von 1-Me-thyl-2-(phenoxymethyl)-5-nitro-imidazolen der Formel I It has now become a process for the preparation of 1-methyl-2- (phenoxymethyl) -5-nitro-imidazoles of the formula I.
(II) (II)
worin A ein Schwefelatom oder eine Sulfoxidgruppe (-SO-), R Methyl oder Äthyl, R1 Methyl und R3 Wasserstoff, Methyl oder Halogen wie Fluor, Chlor, Brom oder Jod bedeuten, oxidiert. wherein A is a sulfur atom or a sulfoxide group (-SO-), R is methyl or ethyl, R1 is methyl and R3 is hydrogen, methyl or halogen such as fluorine, chlorine, bromine or iodine.
25 Die als Ausgangsstoffe verwendeten l-Methyl-2-(phen-oxymethyl)-5-nitro-imidazole der Formel II sind in der CH-PS 605 813 beschrieben. Sie können aus l-Methyl-2-chlorme-thyl-5-nitro-imidazol (erhältlich nach DE-OS 1 595 929 und DE-OS 1 470 102) und gegebenenfalls substituierten Alkyl-30 mercaptophenolen oder Alkylsulfinylphenolen (erhältlich aus den entsprechenden Merkaptophenolen und Dialkylsulfat und gegebenenfalls anschliessende Oxydation mit Perbenzoesäure) in Dimethylformamid und in Gegenwart von Kaliumcarbonat erhalten werden. 25 The l-methyl-2- (phen-oxymethyl) -5-nitro-imidazoles of the formula II used as starting materials are described in CH-PS 605 813. You can from l-methyl-2-chloromethyl-5-nitro-imidazole (available according to DE-OS 1 595 929 and DE-OS 1 470 102) and optionally substituted alkyl-30 mercaptophenols or alkylsulfinylphenols (available from the corresponding mercaptophenols and dialkyl sulfate and, if appropriate, subsequent oxidation with perbenzoic acid) in dimethylformamide and in the presence of potassium carbonate.
35 Als Ausgangsstoffe der Formel II kommen beispielsweise in Frage: 35 Examples of possible starting materials of the formula II are:
l-Methyl-2-(4-methylthio-phenoxymethyl)-5-nitro-imidazol l-Methyl-2-(4-äthylthio-phenoxymethyl)-5-nitro-40 imidazol l-Methyl-2-(3-methyl-4-methylthio-phenoxymethyl)-5-nitro-imidazol l-methyl-2- (4-methylthio-phenoxymethyl) -5-nitro-imidazole l-methyl-2- (4-ethylthio-phenoxymethyl) -5-nitro-40 imidazole l-methyl-2- (3-methyl- 4-methylthio-phenoxymethyl) -5-nitro-imidazole
1 -Methyl -2- (3 -methyl-4-äthylthio-phenoxymethyl)-5-nitro-imidazol 1-Methyl -2- (3-methyl-4-ethylthio-phenoxymethyl) -5-nitro-imidazole
45 l-Methyl-2-(3-fluor-, -chlor-, -brom-, -jod-4-methylthio-phenoxymethyl)-5-nitro-imidazol l-Methyl-2-(3-fluor-, -chlor-, -brom-, -jod-4-äthyIthio- 45 l-methyl-2- (3-fluoro-, -chloro-, -bromo-, -iodo-4-methylthio-phenoxymethyl) -5-nitro-imidazole l-methyl-2- (3-fluoro-, -chlor -, -bromo-, -iodine-4-ethythio-
phenoxymethyl)-5-nitro-imidazol l-MethyI-2-(4-methylsulfinyl-phenoxymethyl)-5-nitro~ so imidazol l-Methyl-2-(4-äthylsulfinyl-phenoxymethyl)-5-nitro-imidazol l-Methyl-2-(3-methyl-4-methylsulfinyl-phenoxymethyl)-5-nitro-imidazol 55 l-Methyl-2-(3-methyl-4-äthylsulfinyl-phenoxymethyl)-5-nitro-imidazol l-Methyl-2-(3-fluor-, -chlor-, -brom-, -jod-4-methyl- phenoxymethyl) -5-nitro-imidazole l-methyl-2- (4-methylsulfinyl-phenoxymethyl) -5-nitro ~ so imidazole l-methyl-2- (4-ethylsulfinyl-phenoxymethyl) -5-nitro-imidazole l-methyl -2- (3-methyl-4-methylsulfinyl-phenoxymethyl) -5-nitro-imidazole 55 l-methyl-2- (3-methyl-4-ethylsulfinyl-phenoxymethyl) -5-nitro-imidazole l-methyl-2- (3-fluorine, chlorine, bromine, iodine-4-methyl
sulfinyl-phenoxymethyl)-5-nitro-imidazol l-Methyl-2-(3-fluor-, -chlor-, -brom-, -jod-4-äthyl-60 sulfinyl-phenoxymethyl)-5-nitro-imidazol sulfinyl-phenoxymethyl) -5-nitro-imidazole 1-methyl-2- (3-fluoro-, -chloro-, -bromo-, -iodo-4-ethyl-60 sulfinyl-phenoxymethyl) -5-nitro-imidazole
Zur Oxydation werden zweckmässig ein- oder zweifach molare Mengen eines Oxydationsmittels verwendet. Oft kann vorteilhaft ein Überschuss des Oxydationsmittels verwendet werden. Verwendet man als Ausgangsstoffe die entsprechenden 65 Sulfide (A = —S— in Formel II), so benötigt man mindestens zwei Moläquivalente Oxydationsmittel. Verwendet man als Ausgangsstoff die entsprechenden Sulfoxide (A = -SO- in Formel II), so benötigt man ein Moläquivalent Oxydationsmit- Single or double molar amounts of an oxidizing agent are expediently used for the oxidation. An excess of the oxidizing agent can often be used advantageously. If the corresponding 65 sulfides (A = —S— in formula II) are used as starting materials, at least two molar equivalents of oxidizing agent are required. If the corresponding sulfoxides (A = -SO- in formula II) are used as the starting material, a molar equivalent of oxidizing agent is required.
624 942 624 942
tel. Als Oxydationsmittel kommen beispielsweise in Frage Wasserstoffperoxid oder Persäuren, wie z.B. Peressigsäure, Pertrifluoressigsäure, Chlorperbenzoesäuren, insbesondere 3-Chlorperbenzoesäure, Salpetersäure, Chromsäure und ihre Salze, Chromsäureanhydrid, Permanganate, Hypochlorite, Chlorate, Perchlorate, Perjodate und Stickoxide, insbesondere Distickstofftetroxid. tel. Possible oxidizing agents are, for example, hydrogen peroxide or peracids, e.g. Peracetic acid, pertrifluoroacetic acid, chloroperbenzoic acids, in particular 3-chloroperbenzoic acid, nitric acid, chromic acid and its salts, chromic anhydride, permanganates, hypochlorites, chlorates, perchlorates, periodates and nitrogen oxides, especially nitrous oxide.
Die Oxydationsreaktionen werden vorteilhaft in einem Lö-sungs- oder Verteilungsmittel durchgeführt. Hierbei eignen sich besonders solche Lösungsmittel, die von dem Oxydationsmittel nicht angegriffen werden, wie z.B. Essigsäure, Tri-fluoressigsäure. Bei Verwendung von Perbenzoesäure eignen sich auch Methylenchlorid und Chloroform als Lösungsmittel. Die Oxydationsreaktionen werden im allgemeinen bei Temperaturen zwischen 0 und 100 °C, insbesondere bei 40-60 °C durchgeführt. Die Reaktionszeiten betragen je nach den Reaktionsbedingungen wenige Minuten bis zu einigen Stunden. The oxidation reactions are advantageously carried out in a solvent or distribution medium. Solvents which are not attacked by the oxidizing agent, such as e.g. Acetic acid, tri-fluoroacetic acid. When using perbenzoic acid, methylene chloride and chloroform are also suitable as solvents. The oxidation reactions are generally carried out at temperatures between 0 and 100 ° C, in particular at 40-60 ° C. Depending on the reaction conditions, the reaction times range from a few minutes to a few hours.
Die Isolierung der Verfahrenserzeugnisse erfolgt durch Verdünnen der Reaktionslösung mit Wasser unter gleichzeitiger Ausfällung, oder durch Eindampfen des organischen Lösungsmittels im Vakuum. Gegebenenfalls kann eine Reinigung durch Umkristallisation aus einem geeigneten Lösungsmittel oder Lösungsmittelgemisch erfolgen. The process products are isolated by diluting the reaction solution with water with simultaneous precipitation, or by evaporating the organic solvent in vacuo. If necessary, cleaning can be carried out by recrystallization from a suitable solvent or solvent mixture.
Beispiel 1 example 1
l-Methyl-2-(4-methylsulfonyl-phenoxymethyl)-5-nitro-imidazol l-methyl-2- (4-methylsulfonylphenoxymethyl) -5-nitro-imidazole
27,9 g (0,1 Mol) l-Methyl-2-(4-methylthio-phenoxy-methyl)-5-nitro-imidazol (Fp. 116 °C) werden in 250 ml Eisessig gelöst und unter Rühren bei Raumtemperatur 24,3 g (0,25 Mol) 35%iges Wasserstoffsuperoxid zugetropft. Durch die exotherme Reaktion erfolgt Temperaturanstieg auf ca. 45 °C. Danach wird noch 1 Stunde auf 60 °C unter Rühren erhitzt. Nach Abkühlen auf Raumtemperatur wird der Ansatz auf 800 ml Eis/Wasser-Gemisch gegossen, die Ausfällung abgesaugt, mit Wasser gewaschen und aus Isopropanol unter Aktivkohlezusatz umkristallisiert. Man erhält so 29 g = 93 % der Theorie l-Methyl-2-(4-methyl-sulfonylphenoxymethyl)-5-nitro-imidazol in Form von gelblichen Kristallen mit einem Fp. 157 °C. An Stelle des Ausgangsstoffes l-Methyl-2-(4-methylthio-s phenoxymethyl)-5-nitro-imidazol kann auch das entsprechende Sulfoxid, 27.9 g (0.1 mol) of l-methyl-2- (4-methylthio-phenoxy-methyl) -5-nitro-imidazole (mp. 116 ° C.) are dissolved in 250 ml of glacial acetic acid and, with stirring at room temperature, 24 , 3 g (0.25 mol) of 35% hydrogen peroxide were added dropwise. The exothermic reaction causes the temperature to rise to approx. 45 ° C. The mixture is then heated to 60 ° C. for 1 hour with stirring. After cooling to room temperature, the batch is poured onto 800 ml of an ice / water mixture, the precipitate is filtered off with suction, washed with water and recrystallized from isopropanol with the addition of activated carbon. This gives 29 g = 93% of theory l-methyl-2- (4-methyl-sulfonylphenoxymethyl) -5-nitro-imidazole in the form of yellowish crystals with a melting point of 157 ° C. Instead of the starting material l-methyl-2- (4-methylthiosphenoxymethyl) -5-nitro-imidazole, the corresponding sulfoxide,
l-Methyl-2-(4-methylsulfinyl-phenoxymethyl)-5-nitro-imidazol l-methyl-2- (4-methylsulfinyl-phenoxymethyl) -5-nitro-imidazole
(Fp. 130 °C) verwendet werden. Es genügt dann die Verwen-lo dung der halben Menge Wasserstoffsuperoxid. Auf gleiche Weise können hergestellt werden: l-Methyl-2-(4-äthylsulfonyl-phenoxymethyl)-5-nitro-imidazol Fp. 132 °C durch Oxydation von l-Methyl-2-(4-äthylthio-phenoxymethyl)-5-nitro-imidazol (Fp. 90 °C) oder i5 l-Methyl-2-(4-äthylsulfinyl-phenoxymethyl)-5-nitro-imidazol (Fp. 103 °C). (Mp 130 ° C) can be used. It is then sufficient to use half the amount of hydrogen superoxide. The following can be prepared in the same way: l-methyl-2- (4-ethylsulfonylphenoxymethyl) -5-nitro-imidazole, mp. 132 ° C. by oxidation of l-methyl-2- (4-ethylthio-phenoxymethyl) -5- nitro-imidazole (mp. 90 ° C) or 15 l-methyl-2- (4-ethylsulfinyl-phenoxymethyl) -5-nitro-imidazole (mp. 103 ° C).
1 -Methyl-2- (3 -methyl-4-methylsulfonyl-phenoxymethyl)-5-nitro-imidazol (Fp. 141 °C) durch Oxydation von l-Methyl-2-(3-methyl-4-methylthio-phenoxymethyl)-5-nitro-20 imidazol (Fp. 108 °C) oder l-Methyl-2-(3-methyl-4-methyl-sulfinyl-phenoxymethyl)-5-nitro-imidazol (Fp. 121 °C). 1-methyl-2- (3-methyl-4-methylsulfonyl-phenoxymethyl) -5-nitro-imidazole (mp. 141 ° C.) by oxidation of l-methyl-2- (3-methyl-4-methylthio-phenoxymethyl) -5-nitro-20 imidazole (mp. 108 ° C) or l-methyl-2- (3-methyl-4-methyl-sulfinyl-phenoxymethyl) -5-nitro-imidazole (mp. 121 ° C).
l-Methyl-2-(3-methyl-4-äthylsulfonyl-phenoxymethyl)-5-nitro-imidazol (Fp. 115 °C) durch Oxydation von l-Methyl-2-(3-methyl-4-äthylthio-phenoxymethyl)-5-nitro-25 imidazol (Fp. 80 °C) oder l-Methyl-2-(3-methyl-4-äthylsulfinyl-phenoxymethyl)-5-ni-tro-imidazol (Fp. 95 °C). l-methyl-2- (3-methyl-4-ethylsulfonyl-phenoxymethyl) -5-nitro-imidazole (mp. 115 ° C.) by oxidation of l-methyl-2- (3-methyl-4-ethylthio-phenoxymethyl) -5-nitro-25 imidazole (mp. 80 ° C) or l-methyl-2- (3-methyl-4-ethylsulfinyl-phenoxymethyl) -5-nitro-imidazole (mp. 95 ° C).
l-Methyl-2-(3-chlor-4-methylsulfonyl-phenoxymethyl)-5-nitro-imidazol durch Oxydation von 30 l-Methyl-2-(3-chlor-4-methylthio-phenoxymethyl)-5-nitro-imidazol oder l-Methyl-2-(3-chlor-4-methylsulfinyl-phenoxy-methyl)-5-nitro-imidazol. l-methyl-2- (3-chloro-4-methylsulfonyl-phenoxymethyl) -5-nitro-imidazole by oxidation of 30 l-methyl-2- (3-chloro-4-methylthio-phenoxymethyl) -5-nitro-imidazole or l-methyl-2- (3-chloro-4-methylsulfinyl-phenoxymethyl) -5-nitro-imidazole.
1 -Methyl-2- (3 -chlor-4- äthylsulfonyl-phenoxymethyl)-5-nitro-imidazol durch Oxydation von 35 l-Methyl-2-(3-chlor-4-äthylthio-phenoxymethyl)-nitro-imidazol oder l-Methyl-2-(3-chlor-4-äthylsulfinyl-phenoxy-methyl)-5-nitro-imidazol. 1-methyl-2- (3-chloro-4-ethylsulfonyl-phenoxymethyl) -5-nitro-imidazole by oxidation of 35 l-methyl-2- (3-chloro-4-ethylthio-phenoxymethyl) -nitro-imidazole or l -Methyl-2- (3-chloro-4-ethylsulfinyl-phenoxy-methyl) -5-nitro-imidazole.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762607789 DE2607789A1 (en) | 1974-12-16 | 1976-02-26 | PROCESS FOR THE PREPARATION OF 1-METHYL-2-(ALKYLSULFONYL)-PHENOXY-METHYL)-5-NITRO-IMIDAZOLE |
Publications (1)
Publication Number | Publication Date |
---|---|
CH624942A5 true CH624942A5 (en) | 1981-08-31 |
Family
ID=5970911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH231377A CH624942A5 (en) | 1976-02-26 | 1977-02-24 | Process for the preparation of 1-methyl-2-(alkylsulphonylphenoxymethyl)-5-nitroimidazoles |
Country Status (12)
Country | Link |
---|---|
AT (1) | AT361468B (en) |
CA (1) | CA1079738A (en) |
CH (1) | CH624942A5 (en) |
DK (1) | DK144524C (en) |
EG (1) | EG13828A (en) |
ES (1) | ES456117A2 (en) |
FI (1) | FI770599A (en) |
IT (1) | IT1115608B (en) |
LU (1) | LU76834A1 (en) |
NL (1) | NL7701838A (en) |
NO (1) | NO770648L (en) |
SE (1) | SE7702126L (en) |
-
1977
- 1977-02-21 NL NL7701838A patent/NL7701838A/en not_active Application Discontinuation
- 1977-02-21 ES ES456117A patent/ES456117A2/en not_active Expired
- 1977-02-23 EG EG111/77A patent/EG13828A/en active
- 1977-02-24 FI FI770599A patent/FI770599A/fi not_active Application Discontinuation
- 1977-02-24 LU LU76834A patent/LU76834A1/xx unknown
- 1977-02-24 CA CA272,551A patent/CA1079738A/en not_active Expired
- 1977-02-24 CH CH231377A patent/CH624942A5/en not_active IP Right Cessation
- 1977-02-24 IT IT20658/77A patent/IT1115608B/en active
- 1977-02-25 NO NO770648A patent/NO770648L/en unknown
- 1977-02-25 AT AT128477A patent/AT361468B/en not_active IP Right Cessation
- 1977-02-25 DK DK84177A patent/DK144524C/en not_active IP Right Cessation
- 1977-02-25 SE SE7702126A patent/SE7702126L/en unknown
Also Published As
Publication number | Publication date |
---|---|
NL7701838A (en) | 1977-08-30 |
DK144524C (en) | 1982-09-06 |
DK84177A (en) | 1977-08-27 |
IT1115608B (en) | 1986-02-03 |
EG13828A (en) | 1982-09-30 |
ES456117A2 (en) | 1978-03-01 |
DK144524B (en) | 1982-03-22 |
NO770648L (en) | 1977-08-29 |
CA1079738A (en) | 1980-06-17 |
ATA128477A (en) | 1980-08-15 |
SE7702126L (en) | 1977-08-27 |
LU76834A1 (en) | 1977-09-26 |
AT361468B (en) | 1981-03-10 |
FI770599A (en) | 1977-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0187349B1 (en) | Process for the preparation of 1,2-benzisothiazolones | |
CH643242A5 (en) | Sulphur containing benzene derivatives and process for producing. | |
DE2740887A1 (en) | AGENTS FOR CONTROLLING PLANT BACTERIOS | |
CH624942A5 (en) | Process for the preparation of 1-methyl-2-(alkylsulphonylphenoxymethyl)-5-nitroimidazoles | |
EP0730007A2 (en) | Cyanation of systems containing double bonds | |
CH625231A5 (en) | ||
DE1300117B (en) | 5-sulfonyl-1,2-dithiol-3-ones | |
DE2607789A1 (en) | PROCESS FOR THE PREPARATION OF 1-METHYL-2-(ALKYLSULFONYL)-PHENOXY-METHYL)-5-NITRO-IMIDAZOLE | |
Sundholm et al. | The Reaction of 2, 3-Dichloro-1, 4-naphthoquinone with Salts of Alkyl Substituted and Unsubstituted Dithiocarbamic Acids | |
DE902010C (en) | Process for the preparation of sulfonamide compounds | |
EP0153656A1 (en) | Method for the preparation of 2,6-dichlorobenzoxazole | |
AT239786B (en) | Process for the preparation of new 3,6-disubstituted 7-sulfamylbenzo-1,1-dioxo-1-thia-2,4-diazine derivatives | |
AT372942B (en) | METHOD FOR PRODUCING DIAMINOTHIOCYANATO-BENZOL DERIVATIVES AND THEIR SALTS | |
DD146184A5 (en) | PROCESS FOR THE PREPARATION OF 1,2,3-THIADIAZOL-5-YL-UREA SUBSTANCES | |
DE1066200B (en) | Process for the preparation of sulfonamides of heterocyclic compounds | |
AT206430B (en) | Process for the preparation of disulfamylaniline compounds | |
DE2334973A1 (en) | NEW BIPHENYL DERIVATIVES | |
DE2706701A1 (en) | 3-Chloro-5-halo-pyridazine derivs. prepn. - by reacting a 1,3,3,3-tetra:halo-propenyl ketone or aldehyde and cyclising the semicarbazone formed | |
DE1217958B (en) | Process for the preparation of 11, 12-dihydro-6H-dibenzo [b, f] - [1, 4] thiazocines | |
DE2432631A1 (en) | Alkyl 5-phenylsulphinyl-2-benzimidazolecarbamate derivs - prepd. by oxidising corresponding 5-phenylthio cpds. | |
AT236401B (en) | Process for the preparation of new benzenesulfonyl semicarbazides | |
AT239243B (en) | Process for the preparation of 2, 3-dicyano-1, 4-dithia-anthrahydroquinone and -anthraquinone | |
CH663957A5 (en) | PROCESS FOR PRODUCTION OF 3,5-DICHLORO-2-PYRIDONE. | |
AT265286B (en) | Process for the production of new sulfonamides | |
CH685053A5 (en) | A process for preparing Halogenphenoxyfettsäure derivatives by selective halogenation and Halogenphenoxyfettsäure derivatives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |